Kidney Cancer News

ADAPT Trial: AGS-003 with Sunitinib for Kidney Cancer

Recent Advances in the Management of Urothelial Carcinomas

Therapeutic algorithm for Renal Cell Carcinoma (RCC)

FDA Grants Breakthrough Therapy Designation to Lenvatinib for Metastatic Renal Cell Carcinoma

Study Suggests Renal Cell Carcinoma Reprograms its Metabolism to Evade Immune System

Pembrolizumab Plus Low-Dose Ipilimumab Safe in Melanoma, Renal Cell Carcinoma


The news headlines shown above for are provided courtesy of